| 28.03.2025 10:35 | OBD | Result of AGM | RNS |
| 17.03.2025 07:00 | OBD | Board Changes | RNS |
| 14.03.2025 17:25 | OBD | Holding(s) in Company | RNS |
| 13.03.2025 16:45 | OBD | Oxford BioDynamics expands UK insurance partnership with Bupa | Alliance |
| 13.03.2025 07:00 | OBD | Expansion of OBD/Bupa UK insurance partnership | Reach |
| 05.03.2025 16:00 | OBD | Publication of 2024 Annual Report | RNS |
| 03.03.2025 07:00 | OBD | PDMR Dealing / Grant of Share Options | RNS |
| 28.02.2025 16:10 | OBD | Oxford Biodynamics shares dive as loss widens despite revenue rise | Alliance |
| 28.02.2025 10:58 | BMK, OBD, ROAD | AIM WINNERS & LOSERS: Oxford BioDynamics and Benchmark slump | Alliance |
| 28.02.2025 07:00 | OBD | Preliminary Results and Notice of AGM | RNS |
| 21.02.2025 12:37 | SXS, RMV, BBOX | UK earnings, trading statements calendar - next 7 days | Alliance |
| 21.02.2025 10:00 | OBD | Notice of Preliminary Results | RNS |
| 17.02.2025 13:07 | OBD | Holding(s) in Company | RNS |
| 12.02.2025 16:48 | OBD | Holding(s) in Company | RNS |
| 12.02.2025 14:00 | OBD | Oxford BioDynamics inks distribution deal with Romanian medical firm | Alliance |
| 12.02.2025 07:00 | OBD | OBD partners with Regina Maria in Romania | Reach |
| 10.02.2025 12:09 | OBD | Holding(s) in Company | RNS |
| 06.02.2025 13:43 | OBD | Holding(s) in Company | RNS |
| 06.02.2025 10:46 | OBD | Holding(s) in Company | RNS |
| 06.02.2025 07:00 | OBD | Holding(s) in Company | RNS |
| 05.02.2025 14:13 | OBD | Holding(s) in Company | RNS |
| 05.02.2025 14:11 | OBD | Holding(s) in Company | RNS |
| 05.02.2025 11:01 | AXL, OBD, MTEC | AIM WINNERS & LOSERS: Arrow Exploration well disappoints | Alliance |
| 05.02.2025 07:00 | OBD | CRC Test Accurately Detects Cancer and Polyps | Reach |
| 04.02.2025 14:38 | OBD | Holding(s) in Company | RNS |
| 31.01.2025 12:00 | OBD | Result of GM and Director Dealings | RNS |
| 23.01.2025 07:00 | OBD | CiRT: Real World Data Presented at ASCO-GI | Reach |
| 17.01.2025 21:43 | OBD | IN BRIEF: Oxford BioDynamics raises GBP350,000 via retail offer | Alliance |
| 17.01.2025 07:00 | OBD | Result of WRAP Retail Offer | RNS |
| 15.01.2025 07:00 | OBD | Result of Placing and Subscription | RNS |
| 14.01.2025 21:20 | OBD | IN BRIEF: Oxford BioDynamics launches GBP6.5 million fund raise | Alliance |
| 14.01.2025 17:09 | OBD | WRAP Retail Offer | RNS |
| 14.01.2025 16:35 | OBD | Proposed Fundraising | RNS |
| 24.12.2024 07:00 | OBD | Issue of shares, Director / PDMR holdings and TVR | RNS |
| 19.12.2024 14:41 | OBD | Shareholder Loan and Related Party Transaction | RNS |
| 16.12.2024 07:00 | OBD | Directorate Change, Funding Update & Joint Broker | RNS |
| 06.12.2024 16:05 | OBD | Holding(s) in Company | RNS |
| 03.12.2024 16:41 | OBD | Response to Share Price Movement | RNS |
| 29.11.2024 11:40 | OBD | Director/PDMR Shareholding | RNS |
| 28.10.2024 12:12 | OBD | Director / PDMR holdings and Total Voting Rights | RNS |
| 25.10.2024 07:00 | OBD | Prognostic Covid Severity Test Study Published | Reach |
| 22.10.2024 13:00 | OBD | CiRT Receives Clinical Approval from NYS CLEP | Reach |
| 15.10.2024 14:34 | OBD | Holding(s) in Company | RNS |
| 14.10.2024 15:34 | OBD | Oxford BioDynamics pledges to cut costs amid need to raise extra funds | Alliance |
| 14.10.2024 07:00 | OBD | Commercial update for FY24 | RNS |
| 07.10.2024 07:01 | OBD | Holding(s) in Company | RNS |
| 07.10.2024 07:00 | OBD | CIRRP Award Update | RNS |
| 11.09.2024 12:55 | OBD | Holding(s) in Company | RNS |
| 22.08.2024 16:59 | OBD | Holding(s) in Company | RNS |
| 22.08.2024 11:41 | OBD | Holding(s) in Company | RNS |
| 25.07.2024 07:00 | OBD | OBD pursuing EpiSwitch as companion diagnostics | Reach |
| 21.06.2024 15:42 | OBD | Grant of Options | RNS |
| 18.06.2024 16:58 | OBD | Oxford BioDynamics revenue up 49% in first half as test sales rise | Alliance |
| 18.06.2024 07:00 | OBD | Half-year Report | RNS |
| 11.06.2024 16:01 | TEP, TAM, OBD | UK earnings, trading statements calendar - next 7 days | Alliance |
| 06.06.2024 07:00 | OBD | OBD's PSE test to be used in NCI trial | Reach |
| 04.06.2024 10:28 | OBD | Oxford BioDynamics develops canine cancer test with 89% accuracy | Alliance |
| 04.06.2024 07:00 | OBD | OBD develops multi-cancer diagnostic test for dogs | Reach |
| 24.05.2024 07:00 | OBD | Notice of Results | RNS |
| 23.05.2024 21:08 | CEL, AET, PHAR | TRADING UPDATES: Celadon ships to US; Oxford BioDynamics-Goodbody pact | Alliance |
| 23.05.2024 07:00 | OBD | OBD partners with Goodbody Clinic on PSE test | RNS |
| 21.05.2024 14:06 | OBD | Oxford BioDynamics to provide tests to largest UK charitable hospital | Alliance |
| 21.05.2024 07:00 | OBD | OBD partners with The London Clinic for PSE & CiRT | RNS |
| 16.05.2024 20:09 | BBOX, MYI, UPL | TRADING UPDATES: Bens Creek considers administration; Nexxen inks deal | Alliance |
| 16.05.2024 07:00 | OBD | OBD and King's College London collaborate on RA | Reach |
| 10.05.2024 13:11 | OBD | Holding(s) in Company | RNS |
| 25.04.2024 14:50 | OBD | Holding(s) in Company | RNS |
| 11.04.2024 14:36 | OBD | Holding(s) in Company | RNS |
| 10.04.2024 16:28 | OBD | Holding(s) in Company | RNS |
| 09.04.2024 17:35 | OBD | Holding(s) in Company | RNS |
| 09.04.2024 12:42 | OBD | Holding(s) in Company | RNS |
| 09.04.2024 11:56 | OBD | Holding(s) in Company | RNS |
| 05.04.2024 16:52 | OBD | Holding(s) in Company | RNS |
| 05.04.2024 08:28 | OBD | Holding(s) in Company | RNS |
| 03.04.2024 14:31 | OBD | Oxford BioDynamics reaches "important milestone" with new laboratory | Alliance |
